[direct reporting network on October 30 news (Conba) to promote the precision of cancer medicine, gene diagnosis and treatment of modern innovation and application, improve the cancer research foundation and the level of clinical diagnosis and treatment, by Zhejiang of Science University, Conba - Zhejiang science and technology "Sino American academician workstation" and China Association of pharmaceutical biotechnology precision medical branch etc. jointly organized the "2015 Hangzhou International precise cancer medicine and modern diagnosis and treatment sessions and Conba Zhejiang and industry and trade between China and the United States academician workstation 2015" in Zhejiang science and Technology University Conference Center.

Conference invited the 2000 Nobel Prize obtained were Richard J.Roberts, academician Liu Xinyuan, Cao Xuetao, Guo Fan Hong academician and torregrosa JV academicians and other experts and scholars at home and abroad to participate in and report on the latest progress in the field, company president Wang Ruwei as members of the presidium of the meeting and convention Organization Committee director to attend the meeting, the R & D department secretary Fangling as guest speakers, at the meeting shared academic report on tumor immunotherapy, subsidiary company of Hangzhou belo Kang Biotechnology Co., Ltd. Cao Wangli, Lin hung lee also participated in the meeting.

Conba - Zhejiang science industry and trade "in the United States and academician workstation" is in the University and Zhejiang Conba Pharmaceutical Co., Ltd. with the support of the government of Zhejiang Province and Zhejiang University of, sponsored by the American Academy of Sciences SteveKay, and Chinese Academy of Sciences Liu Xin Yuan academician, by the Zhejiang Science and Technology University and Zhejiang Conba Pharmaceutical Co., Ltd. jointly established, it is mainly engaged in biomedical advanced research, and strengthen the training of young scientists and students, aims to become introduction of the world's most advanced biomedical technology into China's platform. In addition, it will also serve as a bridge between Chinese and American scientists for academic exchange and the introduction of the world's top talent. The establishment and development of the workstation will not only for Zhejiang and University of technology and Conba company, also in Zhejiang and even in China's biomedical research to a significant role in promoting. Through the efforts, not only will Conba - Zhejiang science industry and trade "in the United States and academician workstation" into a famous international first-class scientific research institutions, but also to become a successful research organic combination model.

At the opening ceremony, the chairman of the board of directors of the company on behalf of the president, and Hu Jiqiang spoke: as the representative of the enterprise very honored to participate in the conference of high specification, high-level, Conba very early and with academician Liu team cooperation in the field of new type of interferon and other biological drugs and anti-tumor, related products has in the United States, Singapore start clinical research; in addition, Conba - Zhejiang science and technology "in the United States and academician workstation" in 2014 was established, focus on docking the introduction of foreign advanced technology cooperation, hope that the future can be in innovation research, the school enterprise cooperation and Zhejiang science and technology cooperation in bio medicine and biological agriculture, also welcome to visit the guidance of Conba.

Fang Ling minister at the meeting to share PD-1 and CTLA-4 antibody drug combination of clinical application in tumor treatment, the response is warm. To participate in the international meetings and special reports, for the construction of Conba key laboratories and enterprise technology center will play a positive role in promoting publicity and. 3

(original title: Conba Zhejiang Polytechnic American academician workstation in 2015)

Editor: small Shen

Interpretation of the hot news, showing sensitive events, more exclusive analysis, in the direct report network micro channel, scan two-dimensional code free reading.